Beam Looks Beyond Liver With Guide Therapeutics Acquisition

Company Pays $120m Upfront

Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule. 3D rendered illustration of DNA.
Beam Therapeutics acquires Guide Therapeutics for $120m upfront and up to $320m in milestones. • Source: Shutterstock

More from R&D

More from Scrip